SavedAdd your journal

Journals / Journal of the Turkish-German Gynecological Association / 2018 / Cilt: 19 - Sayı: 4

The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome

Mustafa ÖZBEK
Melia KARAKÖSE
Erman ÇAKAL
İlknur ÜNSAL
Sanem ÖZTEKİN
Bekir UÇAN
Pınar AKHANLI
Sema HEPŞEN
Pages
215–219
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Characteristics, biochemicalparameters, thyroid hormone and autoantibody levels of groups were investigated.Results: Although; we did not find out a statistically significant difference in TSH and sT4 levels between two groups (p>0.05), anti-TPO andanti-TG antibody levels were determined higher in PCOS group significantly (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects oncomorbidities.
📊
Key Findings & Data:We targeted tocommentate anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) antibody levels and thyroid autoimmunity in PCOS.Material and Methods: One hundred eighty four patients who got the diagnosis of PCOS regard to the revised 2003 Rotterdam criteria wereembodied in this study.
💡
Conclusion & Impact:Characteristics, biochemicalparameters, thyroid hormone and autoantibody levels of groups were investigated.Results: Although; we did not find out a statistically significant difference in TSH and sT4 levels between two groups (p>0.05), anti-TPO andanti-TG antibody levels were determined higher in PCOS group significantly (p
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Thyroid hormone abnormalities are commonly seen in polycystic ovary syndrome (PCOS) and have considerable effects oncomorbidities. The association with PCOS and thyroid autoimmunity which lead to thyroid pathologies are not revealed clearly. We targeted tocommentate anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) antibody levels and thyroid autoimmunity in PCOS.Material and Methods: One hundred eighty four patients who got the diagnosis of PCOS regard to the revised 2003 Rotterdam criteria wereembodied in this study. One hundred six age-matched female volunteers were included in the control group. Characteristics, biochemicalparameters, thyroid hormone and autoantibody levels of groups were investigated.Results: Although; we did not find out a statistically significant difference in TSH and sT4 levels between two groups (p>0.05), anti-TPO andanti-TG antibody levels were determined higher in PCOS group significantly (p

🔖

Cite This Article

ÖZBEK, M., KARAKÖSE, M., ÇAKAL, E., ÜNSAL, İ., ÖZTEKİN, S., UÇAN, B., AKHANLI, P., HEPŞEN, S. (2022). The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome. Journal of the Turkish-German Gynecological Association, Cilt: 19 - Sayı: 4, 215–219. https://ajindex.com/articles/567508

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-9
  2. Geisthövel F, Rabe T. The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS)-an extended critical analysis. Reprod Biomed Online 2007; 14: 522-35
  3. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141-6
  4. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 1929-35
  5. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 1357-63
  6. Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001; 111: 607-13
  7. Kennedy RL, Malabu UH, Jarrod G, Nigam P, Kannan K, Rane A. Thyroid function and pregnancy: before, during and beyond. J Obstet Gynaecol 2010; 30: 774-83
  8. Poppe K, Glinoer D, Van Steirteghem A, Tournaye H, Devroey P, Schiettecatte J, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 2002; 12: 997-1001
  9. Medenica S, Nedeljkovic O, Radojevic N, Stojkovic M, Trbojevic B, Pajovic B. Thyroid dysfunction and thyroid autoimmunity in euthyroid women in achieving fertility. Eur Rev Med Pharmacol Sci 2015; 19: 977-87
  10. Kousta E, White DM, Cela E, McCarthy MI, Franks S. The prevalence of polycystic ovaries in women with infertility. Hum Reprod 1999; 14: 2720-3
  11. Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2012; 285: 853-6
  12. Calvar CE, Bengolea SV, Deutsch SI, Hermes R, Ramos G, Loyato M. High frequency of thyroid abnormalities in polycystic ovary syndrome. Medicina (B Aires) 2015; 75: 213-7
  13. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-7
  14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma g